When 15-year-old Anna Hankins accepted the title of Miss Amazing in Chicago, the Mississippi teen was beaming not only because of the award, but also because of the opportunity to raise awareness ...

An Australian study reveals that people with the rare genetic disorder known as Prader-Willi Syndrome may have an impaired autonomic nervous system. This discovery opens up a new way of looking at the ...

Stem cell researchers have reversed Prader-Willi syndrome in brain cells growing in the lab. The discovery provides clues that could lead to a treatment for Prader-Willi, a genetic disorder that ...

Haley Kavrell, 17, who must cope with Prader-Willi syndrome, which causes her to feel constant hunger, picks basil at her home in Davis late last month. Renée C. Byer [email protected] After receiving ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Two presentations at the 2018 Foundation ...

Company will host a webcast at 10am ET on November 6, 2025, to discuss its Phase 2a study to assess efficacy, safety and ...

DENVER (CBS4) - We are fast approaching Thanksgiving, the national holiday that puts a lot of focus on food. Two mothers in the Stapleton neighborhood are focusing on fitness instead. They are holding ...

The FDA granted orphan drug designation to an investigational drug for the treatment of Prader-Willi syndrome, according to an industry press release. Tesomet (Saniona) is an investigational, ...

WE’LL TALK TO YOU LATER. WELL, IMAGINE EATING ENOUGH MAYBE TOO MUCH, BUT NEVER FEELING FULL. THAT’S WHAT A NORTHLAND TODDLER LIVES WITH EVERY DAY. AND THIS WORLD WHERE DISEASE DAY CAME DECISIONS DONNA ...

Soleno Therapeutics’ Vykat XR is now FDA approved for treating hyperphagia, or excessive hunger, in patients with Prader-Willi syndrome. The once-daily pill is the first approved therapy for this rare ...

The Key Prader-Willi Syndrome Companies in the market include - Novo Nordisk, Pfizer, Sandoz, Harmony Biosciences, Soleno Therapeutics, Harmony Biosciences, ACADIA Pharmaceuticals, Aardvark ...

Soleno Therapeutics Inc. (NASDAQ: SLNO) pulled off in a major way its randomized-withdrawal phase III study with DCCR (diazoxide choline) in Prader-Willi syndrome, boosting the shares by $22.37, or ...